BhardwajDesaiMD

Oncology • Prospect Heights, IL

Oncology innovation

Join to view full profile

Dr. Desai is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Desai's full profile

Already have an account?

Office
405 Walden lane
Prospect Heights, IL 60070
Phone+1 630-289-6460

Education & Training

Baroda Medical CollegeClass of 1985

Clinical Trials

A Phase I Study of ABT-888 in Combination With Temozolomide in Cancer Patients Start of enrollment: 2007 Aug 01
Completed
Phase 1
A Study Combining ABT-888, Oral PARP Inhibitor, With Temozolomide in Patients With Metastatic Prostate Cancer Start of enrollment: 2010 Apr 01
Completed
Phase 1
To Determine the Food Effect and Bioavailability of Three Formulations of Veliparib in Subjects With Solid Tumors Start of enrollment: 2010 Jun 01
Completed
Phase 1

Publications & Presentations

PubMed

25 citations
A Phase I, Dose Escalation Study of Oral ASP8273 in Patients with Non-small Cell Lung Cancers with Epidermal Growth Factor Receptor Mutations.
Helena A. Yu, Alexander I. Spira, Leora Horn, Jared Weiss, Howard West
Clinical Cancer Research. 2017-12-15

Press Mentions

Penrose TherapeuTx Expands Scientific Advisory Board with Three World-Renowned Oncology ResearchersApril 6th, 2021
Ex-Vividion Chief Diego Miralles Finds 'Dream Team' at Stealthy Flagship Portfolio Company; Astellas Looks Inward to Select CBO and CSOFebruary 12th, 2021
Chutes & Ladders—After Verastem Pit Stop, Bluebird Vet Neumann Lands at KiteFebruary 12th, 2021
Join now to see all